glp-1 receptor agonists as Treatments for Type 2 Diabetes adverse effects of glp-1 receptor

Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials

Treatment with dulaglutide showed similar inhibitory effects on C max and t max , but the AUC of atorvastatin was reduced (0.786, 90% CI 0.7520.821) [15], as with co-administration of albiglutide [29]

Cartwright MJ, Tchkonia T, Kirkland JL

N Engl J Med (2016) 375:183444

R.DiazR.LakshmananM.PaisP.et al (2019)

If youre considering treatment with a GLP-1 agonist, todays blog is no substitute for a personal conversation with your healthcare provider